Dermatheek SRL
30.0 FTEThe score of Dermatheek shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +50 % Total assets +48 % Headcount (avg FTE) +38 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dermatheek's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 291,540 € | ||||
| Equity | 905,242 € | ||||
| Cash | 319,074 € | ||||
| EBITDA | 712,870 € | ||||
| Total assets | €5.46m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Nov 2026
- Year ended 31 Dec 2024filed on 14 Aug 2025
- Year ended 31 Dec 2023filed on 13 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
Dermatheek's financial analysis
- Solvency16.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dermatheek
Dermatheek's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0441.223.009
- VAT number
- BE0441223009
- Peppol
- Registered · 0208:0441223009 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Jul 1990
- Registered office
- 2520 Ranst
- Size
- Small · 30.0 FTE
- Latest accounts
- 2025 · filed on 03 Nov 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Dermatheek (SRL) has been based in Ranst since 1990, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 291,540 € and equity of 905,242 €; its revenue is not published. With 30.0 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 16.6%, below the median of its sector (44.2%).
Companies similar to Dermatheek
Companies in the same business, of comparable size and area, outside its group.
- Upjohn Manufacture of pharmaceutical preparations Hoeilaart · balance sheet €12.3m
- BePharBel Manufacturing Manufacture of basic pharmaceutical products Courcelles · balance sheet €27.4m
- Pharma Force Retail sale of pharmaceutical products Ghent · balance sheet €15.7m
- Holland & Barrett Retail sale of other food Antwerp · balance sheet €10.6m
- Apotheken Solidaris Retail sale of pharmaceutical products Hasselt · balance sheet €8.84m
- LA Compagnie Financiere ET Immobiliere DU Haut Escaut Retail sale of pharmaceutical products Tournai · balance sheet €2.24m
- Apovlam Retail sale of pharmaceutical products Ypres · balance sheet €11.0m
- IVALI Company Wholesale of perfume and cosmetics Ixelles · balance sheet €3.92m
Frequently asked questions about Dermatheek
What is the revenue of Dermatheek?
Dermatheek files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dermatheek?
In Belgium, the VAT number is the company number prefixed with BE: BE0441223009 for Dermatheek, if the company is VAT-registered. Its company number (CBE) is 0441.223.009.
Where is the registered office of Dermatheek?
According to the CBE register, the registered office of Dermatheek is in 2520 Ranst.
What is the equity of Dermatheek?
At the close of the 2025 financial year, the equity of Dermatheek amounts to 905,242 €, a solvency of 16.6% of total assets.
How many people work at Dermatheek?
30.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Dermatheek?
The register lists 7 active mandates at Dermatheek. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dermatheek
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →